Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening.

MLA

Xu, Mei Ling, et al. “Serum Anti-GAPDH Autoantibody Levels Reflect the Severity of Cervical Lesions: A Potential Serum Biomarker for Cervical Cancer Screening.” Oncology Letters, vol. 18, no. 1, July 2019, pp. 255–64. EBSCOhost, https://doi.org/10.3892/ol.2019.10326.

APA

Xu, M. L., Kim, H. J., Kim, S. C., Ju, W., Kim, Y. H., Chang, K.-H., & Kim, H.-J. (2019). Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening. Oncology Letters, 18(1), 255–264. https://doi.org/10.3892/ol.2019.10326

Chicago

Xu, Mei Ling, Hyoung Jin Kim, Seung Cheol Kim, Woong Ju, Yun Hwan Kim, Kyu-Ho Chang, and Hong-Jin Kim. 2019. “Serum Anti-GAPDH Autoantibody Levels Reflect the Severity of Cervical Lesions: A Potential Serum Biomarker for Cervical Cancer Screening.” Oncology Letters 18 (1): 255–64. doi:10.3892/ol.2019.10326.